Elanco Animal Health (NYSE:ELAN) Releases Q3 2026 Earnings Guidance
2 Articles
2 Articles
Elanco Saúde Animal announced results above expectations in the second quarter of 2026 and revised its financial projections for the remainder of the year. Between April and June, the company recorded global revenue of US$ 1,368 billion, growth of 10% compared to the same period of 2025 (8% in constant currency), driven mainly by the performance of its innovation portfolio, with emphasis on ZenreliaTM and Crelio QuattroTM. With performance, the …
Elanco Animal Health (NYSE:ELAN) Releases Q3 2026 Earnings Guidance
Elanco Animal Health (NYSE:ELAN) updated its third quarter 2026 earnings guidance. The company provided EPS guidance of 0.190-0.220 for the period, compared to the consensus estimate of 0.190. The company also issued revenue guidance of $1.2 billionillion-$1.2 billionillion, compared to the consensus estimate of $1.2 billionillion.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
